Top Markets
#1 Siacoin Siacoin +46.22%
#2 Official Trump Official Trump +31.38%
#3 Nockchain Nockchain +22.15%
#4 EXOD EXOD +18.93%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +18.89%
#6 MowCat MowCat +18.59%
#7 Melania Meme Melania Meme +17.86%
#8 Power Ledger Power Ledger +17.78%
#9 Mubarak Mubarak +14.98%
#10 Unit Pump Unit Pump +14.81%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
Biocorp Production Biocorp Production

Biocorp Production

ALCOR
Rank in Stocks #23379
Based in Issoire, France, Biocorp Production, established in 2004, specializes... Based in Issoire, France, Biocorp Production, established in 2004, specializes in the innovation and production of medical devices and advanced drug delivery systems. The company offers a suite of intelligent products, such as Inspair, a smart cap designed to track inhaler usage, and Mallya, an intelligent cap for pen injectors that logs vital injection details. Its portfolio also features motor-driven solutions like Onejet, a single-use auto-injector engineered for administering high-viscosity medications, and the Datapen pen injector. Furthermore, Injay serves as a data collection tool, compiling critical information including injection completion, date and time, drug type, batch identifiers, and expiration dates. Biocorp's offerings extend to other pharmaceutical aids, such as NEWGUARD, a safety apparatus for various prefilled syringe sizes, the needle-integrated BIOPASS reconstitution system, and diverse closure mechanisms.
Share Price
$37.21
Last synced: 2023-10-20
Market Cap
$74.42M
Change (1 day)
0.19%
Change (1 year)
0.00%
Country
FR
Trade Biocorp Production (ALCOR)

Category

Healthcare
P/E ratio for Biocorp Production (ALCOR)
P/E ratio as of 2026 TTM: 0
According to Biocorp Production latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Biocorp Production from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.